GB0201498D0 - Materials and methods for treating cancer - Google Patents
Materials and methods for treating cancerInfo
- Publication number
- GB0201498D0 GB0201498D0 GBGB0201498.3A GB0201498A GB0201498D0 GB 0201498 D0 GB0201498 D0 GB 0201498D0 GB 0201498 A GB0201498 A GB 0201498A GB 0201498 D0 GB0201498 D0 GB 0201498D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- materials
- methods
- treating cancer
- cancer
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0201498.3A GB0201498D0 (en) | 2002-01-23 | 2002-01-23 | Materials and methods for treating cancer |
US10/502,470 US20060127896A1 (en) | 2002-01-23 | 2003-01-23 | Materials and methods for treating cancer |
PCT/GB2003/000329 WO2003062826A2 (en) | 2002-01-23 | 2003-01-23 | Materials and methods for examining and treating nasopharyngeal carcinoma |
CNB038060302A CN1325918C (en) | 2002-01-23 | 2003-01-23 | Materials and methods for examining and treating nasopharyngeal carcinoma |
HK05110342A HK1078646A1 (en) | 2002-01-23 | 2005-11-18 | Materials and methods for examining and treating nasopharyngeal carcinoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0201498.3A GB0201498D0 (en) | 2002-01-23 | 2002-01-23 | Materials and methods for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0201498D0 true GB0201498D0 (en) | 2002-03-13 |
Family
ID=9929586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0201498.3A Ceased GB0201498D0 (en) | 2002-01-23 | 2002-01-23 | Materials and methods for treating cancer |
Country Status (5)
Country | Link |
---|---|
US (1) | US20060127896A1 (en) |
CN (1) | CN1325918C (en) |
GB (1) | GB0201498D0 (en) |
HK (1) | HK1078646A1 (en) |
WO (1) | WO2003062826A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1776181B1 (en) | 2004-01-26 | 2013-09-11 | The President and Fellows of Harvard College | Fluid delivery system and method |
US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
WO2007038402A1 (en) * | 2005-09-22 | 2007-04-05 | China Synthetic Rubber Corporation | Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas |
US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
CN101104852A (en) * | 2006-07-10 | 2008-01-16 | 中山大学肿瘤防治中心 | Human novel gene LOC344967 and its encoded protein product related to nasopharyngeal carcinoma |
MY186676A (en) | 2011-08-30 | 2021-08-05 | Astex Pharmaceuticals Inc | Drug formulations |
WO2014158367A1 (en) | 2013-03-13 | 2014-10-02 | Opko Diagnostics, Llc | Mixing of fluids in fluidic systems |
KR102587637B1 (en) | 2014-12-12 | 2023-10-10 | 옵코 다이어그노스틱스, 엘엘씨 | Fluidic systems comprising an incubation channel, including fluidic systems formed by molding |
MX2018000016A (en) | 2015-07-02 | 2019-01-31 | Otsuka Pharma Co Ltd | Lyophilized pharmaceutical compositions. |
WO2019025863A2 (en) | 2017-08-03 | 2019-02-07 | Otsuka Pharmaceutical Co., Ltd. | Drug compound and purification methods thereof |
TWI680297B (en) * | 2018-07-04 | 2019-12-21 | 長庚大學 | A method for evaluating whether an individual with cancer suitable for applying anti-cancer drugs |
CN113559094A (en) * | 2021-08-25 | 2021-10-29 | 西北农林科技大学 | Application of sodium ascorbate |
-
2002
- 2002-01-23 GB GBGB0201498.3A patent/GB0201498D0/en not_active Ceased
-
2003
- 2003-01-23 US US10/502,470 patent/US20060127896A1/en not_active Abandoned
- 2003-01-23 CN CNB038060302A patent/CN1325918C/en not_active Expired - Fee Related
- 2003-01-23 WO PCT/GB2003/000329 patent/WO2003062826A2/en not_active Application Discontinuation
-
2005
- 2005-11-18 HK HK05110342A patent/HK1078646A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1643377A (en) | 2005-07-20 |
WO2003062826A2 (en) | 2003-07-31 |
HK1078646A1 (en) | 2006-03-17 |
CN1325918C (en) | 2007-07-11 |
US20060127896A1 (en) | 2006-06-15 |
WO2003062826A3 (en) | 2003-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003293194A8 (en) | Compositions and methods for treating prostate cancer | |
AU2003230750A1 (en) | Compositions and methods for treating cancer | |
AU2003284242A8 (en) | Methods and compositions for use in treating cancer | |
EP2671581B8 (en) | Compositions and methods for treating cancer | |
AU2003226301A8 (en) | Method of treating cancer | |
EP1468118A4 (en) | Methods and compositions for treating cancer | |
AU2003256847A8 (en) | Method of treating cancer | |
IL164219A0 (en) | Method for treating and preventing hyparathyroidism | |
EP1567198A4 (en) | Materials and methods for treating ocular-related disorders | |
EP1572118A4 (en) | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
AU2003268032A8 (en) | Composition and methods for treatment and screening | |
GB0201498D0 (en) | Materials and methods for treating cancer | |
PL379264A1 (en) | Compositions and methods for treating cancer using igsf9 and liv-1 | |
EP1401377A4 (en) | Methods for treating cancer | |
AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
AU2003225461A8 (en) | Composition and method for supporting cancer treatments | |
EP1684795A4 (en) | Methods and agents for the treatment of cancer | |
AU2002305138A1 (en) | Methods and materials for cancer treatment | |
GB0223325D0 (en) | Treating cancer | |
EP1599214A4 (en) | Methods and compositions for treating cervical cancer | |
AU2003295604A8 (en) | Gpc15: methods and compositions for treating cancer | |
AU2003209265A8 (en) | Mrp9 and its use detecting and treating cancer | |
IL166025A0 (en) | Combination therapy and means for carrying out said therapy | |
AU2003281245A1 (en) | Compounds and methods for treating cancer and inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |